Literature DB >> 23209232

Genome sequences of two multidrug-resistant Acinetobacter baumannii strains isolated from a patient before and after treatment with tigecycline.

Xiaoting Hua1, Hua Zhou, Yan Jiang, Ye Feng, Qiong Chen, Zhi Ruan, Yunsong Yu.   

Abstract

Acinetobacter baumannii is a Gram-negative bacterium which emerged as a significant nosocomial pathogen worldwide. To investigate the molecular basis of the tigecycline-resistant mechanism, we determined the genome sequences of two multidrug-resistant A. baumannii strains isolated from a patient before and after treatment with tigecycline.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23209232      PMCID： PMC3510637          DOI： 10.1128/JB.01887-12

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  10 in total

1.  Multidrug-resistant Acinetobacter: a threat to the antibiotic era.

Authors:  A Y Peleg; D L Paterson
Journal:  Intern Med J       Date:  2006-08       Impact factor: 2.048

2.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

Review 3.  Acinetobacter infection.

Authors:  L Silvia Munoz-Price; Robert A Weinstein
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

4.  AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii.

Authors:  Michael Hornsey; Matthew J Ellington; Michel Doumith; Claire P Thomas; Nicola C Gordon; David W Wareham; John Quinn; Karen Lolans; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2010-06-16       Impact factor: 5.790

5.  Genomic analysis of the multidrug-resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China.

Authors:  Hua Zhou; Tongwu Zhang; Dongliang Yu; Borui Pi; Qing Yang; Jianying Zhou; Songnian Hu; Yunsong Yu
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

6.  Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy.

Authors:  Michael Hornsey; Nick Loman; David W Wareham; Matthew J Ellington; Mark J Pallen; Jane F Turton; Anthony Underwood; Tom Gaulton; Claire P Thomas; Michel Doumith; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2011-05-12       Impact factor: 5.790

Review 7.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 8.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Authors:  Lenie Dijkshoorn; Alexandr Nemec; Harald Seifert
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

9.  Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii.

Authors:  Mark D Adams; Karrie Goglin; Neil Molyneaux; Kristine M Hujer; Heather Lavender; Jennifer J Jamison; Ian J MacDonald; Kristienna M Martin; Thomas Russo; Anthony A Campagnari; Andrea M Hujer; Robert A Bonomo; Steven R Gill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

Review 10.  Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.

Authors:  Drosos E Karageorgopoulos; Matthew E Falagas
Journal:  Lancet Infect Dis       Date:  2008-12       Impact factor: 25.071
  10 in total
  5 in total

Review 1.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Activation of phenotypic subpopulations in response to ciprofloxacin treatment in Acinetobacter baumannii.

Authors:  Ashley E Macguire; Meining Carly Ching; Brett H Diamond; Alexey Kazakov; Pavel Novichkov; Veronica G Godoy
Journal:  Mol Microbiol       Date:  2014-03-03       Impact factor: 3.501

3.  AdeRS combination codes differentiate the response to efflux pump inhibitors in tigecycline-resistant isolates of extensively drug-resistant Acinetobacter baumannii.

Authors:  J-R Sun; C-L Perng; J-C Lin; Y-S Yang; M-C Chan; T-Y Chang; F-M Lin; T-S Chiueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-18       Impact factor: 3.267

4.  Complete Genome Sequence of Klebsiella pneumoniae Sequence Type 17, a Multidrug-Resistant Strain Isolated during Tigecycline Treatment.

Authors:  Xiaoting Hua; Qiong Chen; Xi Li; Ye Feng; Zhi Ruan; Yunsong Yu
Journal:  Genome Announc       Date:  2014-12-24

5.  The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii.

Authors:  Xinli Mu; Nanfei Wang; Xi Li; Keren Shi; Zhihui Zhou; Yunsong Yu; Xiaoting Hua
Journal:  Front Microbiol       Date:  2016-11-01       Impact factor: 5.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.